CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Lifitegrast

利非司特 杂质对照品Lifitegrast Impurities

70 个杂质条目70 impurity entries

本页汇总 利非司特 的 70 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 70 impurity reference standards of Lifitegrast. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 利非司特(Lifitegrast)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesA specific chiral HPLC method for lifitegrast and determination of enantiomeric impurity in drug substance, ophthalmic product and stressed samples
    Journal of pharmaceutical and biomedical analysis · 2024 · Uğur M et al.  ·  PMID 38387128  ·  DOI
  2. 杂质研究Impurity studiesEffect of Citric Acid and Tromethamine on the Stability of Eyedrops Containing Lifitegrast
    Pharmaceuticals (Basel, Switzerland) · 2024 · Jeong JS et al.  ·  PMID 39598327  ·  DOI
  3. 分析方法Analytical MethodsSimultaneous quantification of lifitegrast and Rebamipide in hydrogel-based contact lenses using spectroscopic method
    International ophthalmology · 2026 · Patel YR et al.  ·  PMID 41790315  ·  DOI
  4. 分析方法Analytical MethodsAn LC-MS/MS method for the determination of Lifitegrast in human plasma and tear and its application in the pharmacokinetic study
    Bioanalysis · 2024 · Juan C et al.  ·  PMID 39088034  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisPractical Synthesis of 5,7-Dichlorotetrahydroisoquinoline-6-carboxylic Acid-Key Intermediate of Lifitegrast (Xiidra)
    ACS omega · 2023 · Liu X et al.  ·  PMID 37273640  ·  DOI

利非司特 —— 原料药与杂质对照品Lifitegrast — drug substance & impurities

共 71 个条目(含原料药本体)71 items incl. the drug substance
Lifitegrast structure
原料药 APIAPI
立他司特Lifitegrast
Lifitegrast
CAS No.1025967-78-5
Chemical FormulaC29H24Cl2N2O7S
Purity>95%现货In stock
10mg25mg50mg100mg
Lifitegrast Dicyclohexylamine structure
—
利非司特二环已胺Lifitegrast Dicyclohexylamine
Lifitegrast Dicyclohexylamine
CAS No.2271054-94-3
Chemical FormulaC29H24Cl2N2O7S·C12H23N
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 1 structure
1
利非司特杂质1Lifitegrast Impurity 1
Lifitegrast Impurity 1
CAS No.1194550-61-2
Chemical FormulaC32H34Cl2N2O7S
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 2 structure
2
利非司特杂质2Lifitegrast Impurity 2
Lifitegrast Impurity 2
CAS No.2049127-88-8
Chemical FormulaC17H19NO4S·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 4 structure
4
利非司特杂质4Lifitegrast Impurity 4
Lifitegrast Impurity 4
CAS No.1194864-18-0
Chemical FormulaC27H26Cl2N2O5S
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 5 structure
5
利非司特杂质5Lifitegrast Impurity 5
Lifitegrast Impurity 5
CAS No.1289646-93-0
Chemical FormulaC10H9Cl2NO2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 6 structure
6
利非司特杂质6Lifitegrast Impurity 6
Lifitegrast Impurity 6
CAS No.2724318-80-1
Chemical FormulaC27H26Cl2N2O5S
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 7 structure
7
利非司特杂质7Lifitegrast Impurity 7
Lifitegrast Impurity 7
CAS No.1194550-67-8
Chemical FormulaC36H30Cl2N2O7S
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 9 structure
9
利非司特杂质9Lifitegrast Impurity 9
Lifitegrast Impurity 9
CAS No.1289646-90-7
Chemical FormulaC11H10O3
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 10 structure
10
利非司特杂质10Lifitegrast Impurity 10
Lifitegrast Impurity 10
CAS No.2129597-34-6
Chemical FormulaC19H13Cl2NO4
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 12 structure
12
利非司特杂质12Lifitegrast Impurity 12
Lifitegrast Impurity 12
CAS No.2271299-08-0
Chemical FormulaC29H24Cl2N2O7S
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 14 structure
14
利非司特杂质14Lifitegrast Impurity 14
Lifitegrast Impurity 14
CAS No.1194550-59-8
Chemical FormulaC17H19NO4S·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 15 structure
15
利非司特杂质15Lifitegrast Impurity 15
Lifitegrast Impurity 15
CAS No.1270093-99-6
Chemical FormulaC10H13NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 15 Hydrochloride structure
15
利非司特杂质15 盐酸盐Lifitegrast Impurity 15 Hydrochloride
Lifitegrast Impurity 15 Hydrochloride
CAS No.2177264-60-5
Chemical FormulaC10H13NO4S·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 16 structure
16
利非司特杂质16Lifitegrast Impurity 16
Lifitegrast Impurity 16
CAS No.1270132-45-0
Chemical FormulaC10H13NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 17 structure
17
利非司特杂质17Lifitegrast Impurity 17
Lifitegrast Impurity 17
CAS No.851784-82-2
Chemical FormulaC15H17Cl2NO4
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 18 structure
18
利非司特杂质18Lifitegrast Impurity 18
Lifitegrast Impurity 18
CAS No.14046-52-7
Chemical FormulaC9H10Cl3N·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 19 structure
19
利非司特杂质19Lifitegrast Impurity 19
Lifitegrast Impurity 19
CAS No.73075-47-5
Chemical FormulaC9H9Cl2N·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 19 Monomer structure
19
利非司特杂质19 单体Lifitegrast Impurity 19 Monomer
Lifitegrast Impurity 19 Monomer
CAS No.89315-56-0
Chemical FormulaC9H9Cl2N
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 20 structure
20
利非司特杂质20Lifitegrast Impurity 20
Lifitegrast Impurity 20
CAS No.1289646-72-5
Chemical FormulaC28H23Cl2N
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 21 structure
21
利非司特杂质21Lifitegrast Impurity 21
Lifitegrast Impurity 21
CAS No.1194550-56-5
Chemical FormulaC29H23Cl2NO2
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 22 structure
22
利非司特杂质22Lifitegrast Impurity 22
Lifitegrast Impurity 22
CAS No.301836-57-7
Chemical FormulaC9H8O3
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 23 structure
23
利非司特杂质23Lifitegrast Impurity 23
Lifitegrast Impurity 23
CAS No.2271054-95-4
Chemical FormulaC20H20Cl2N2O5S·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 23 Monomer structure
23
利非司特杂质23 单体Lifitegrast Impurity 23 Monomer
Lifitegrast Impurity 23 Monomer
CAS No.851785-70-1
Chemical FormulaC20H20Cl2N2O5S
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 25 structure
25
利非司特杂质25Lifitegrast Impurity 25
Lifitegrast Impurity 25
CAS No.2295862-29-0
Chemical FormulaC30H26Cl2N2O7S
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 26 structure
26
利非司特杂质26Lifitegrast Impurity 26
Lifitegrast Impurity 26
CAS No.2295862-24-5
Chemical FormulaC31H28Cl2N2O7S
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 27 structure
27
利非司特杂质27Lifitegrast Impurity 27
Lifitegrast Impurity 27
CAS No.2322380-15-2
Chemical FormulaC29H25ClN2O7S
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 28 structure
28
利非司特杂质28Lifitegrast Impurity 28
Lifitegrast Impurity 28
CAS No.2322380-18-5
Chemical FormulaC29H25ClN2O7S
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 31 structure
31
利非司特杂质31Lifitegrast Impurity 31
Lifitegrast Impurity 31
CAS No.3053861-51-8
Chemical FormulaC28H24Cl2N2O9S
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 33 structure
33
利非司特杂质33Lifitegrast Impurity 33
Lifitegrast Impurity 33
CAS No.77095-51-3
Chemical FormulaC9H6O3
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 34 structure
34
利非司特杂质34Lifitegrast Impurity 34
Lifitegrast Impurity 34
CAS No.852021-86-4
Chemical FormulaC11H11Cl2NO2
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 35 structure
35
利非司特杂质35Lifitegrast Impurity 35
Lifitegrast Impurity 35
CAS No.588703-29-1
Chemical FormulaC10H8O3
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 36 structure
36
利非司特杂质36Lifitegrast Impurity 36
Lifitegrast Impurity 36
CAS No.1289646-76-9
Chemical FormulaC15H21NO6S
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 37 structure
37
利非司特杂质37Lifitegrast Impurity 37
Lifitegrast Impurity 37
CAS No.82278-73-7
Chemical FormulaC14H18BrNO4
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 41 structure
41
利非司特杂质41Lifitegrast Impurity 41
Lifitegrast Impurity 41
CAS No.1156547-55-5
Chemical FormulaC9H5ClO2
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 43 structure
43
利非司特杂质43Lifitegrast Impurity 43
Lifitegrast Impurity 43
CAS No.3097178-75-8
Chemical FormulaC29H22Cl2N2O7S
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 46 structure
46
利非司特杂质46Lifitegrast Impurity 46
Lifitegrast Impurity 46
CAS No.2762168-17-0
Chemical FormulaC25H28Cl2N2O7S
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 47 structure
47
利非司特杂质47Lifitegrast Impurity 47
Lifitegrast Impurity 47
CAS No.1289646-78-1
Chemical FormulaC22H27NO6S
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 48 structure
48
利非司特杂质48Lifitegrast Impurity 48
Lifitegrast Impurity 48
CAS No.1057218-08-2
Chemical FormulaC21H24BrNO4
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 50 structure
50
利非司特杂质50Lifitegrast Impurity 50
Lifitegrast Impurity 50
CAS No.2215846-47-0
Chemical FormulaC14H17Cl2NO2
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 51 structure
51
利非司特杂质51Lifitegrast Impurity 51
Lifitegrast Impurity 51
CAS No.90721-27-0
Chemical FormulaC9H6O3
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 52 structure
52
利非司特杂质52Lifitegrast Impurity 52
Lifitegrast Impurity 52
CAS No.90484-22-3
Chemical FormulaC9H6O3
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 53 structure
53
利非司特杂质53Lifitegrast Impurity 53
Lifitegrast Impurity 53
CAS No.166599-84-4
Chemical FormulaC9H6O3
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 54 structure
54
利非司特杂质54Lifitegrast Impurity 54
Lifitegrast Impurity 54
CAS No.2295862-00-7
Chemical FormulaC29H26N2O7S
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 56 structure
56
利非司特杂质56Lifitegrast Impurity 56
Lifitegrast Impurity 56
CAS No.2641788-18-1
Chemical FormulaC39H35Cl2N3O10S2
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 58 structure
58
利非司特杂质58Lifitegrast Impurity 58
Lifitegrast Impurity 58
CAS No.16817-24-6
Chemical FormulaC11H10O3
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 82 structure
82
利非司特杂质82Lifitegrast Impurity 82
Lifitegrast Impurity 82
CAS No.2832127-60-1
Chemical FormulaC15H17BrClNO4
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 83 structure
83
利非司特杂质83Lifitegrast Impurity 83
Lifitegrast Impurity 83
CAS No.2637374-15-1
Chemical FormulaC10H8Cl2N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 84 structure
84
利非司特杂质84Lifitegrast Impurity 84
Lifitegrast Impurity 84
CAS No.2832100-74-8
Chemical FormulaC15H17BrClNO4
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 85 structure
85
利非司特杂质85Lifitegrast Impurity 85
Lifitegrast Impurity 85
CAS No.876108-97-3
Chemical FormulaC9H9Cl2NO
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 87 structure
87
利非司特杂质87Lifitegrast Impurity 87
Lifitegrast Impurity 87
CAS No.2509090-73-5
Chemical FormulaC29H24Cl2N2O7S
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 88 structure
88
利非司特杂质88Lifitegrast Impurity 88
Lifitegrast Impurity 88
CAS No.2294008-96-9
Chemical FormulaC15H5F5O3
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 90 structure
90
利非司特杂质90Lifitegrast Impurity 90
Lifitegrast Impurity 90
CAS No.2414639-05-5
Chemical FormulaC33H32Cl2N2O7S
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 91 structure
91
利非司特杂质91Lifitegrast Impurity 91
Lifitegrast Impurity 91
CAS No.2260511-33-7
Chemical FormulaC24H15Cl2N5O4
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 92 structure
92
利非司特杂质92Lifitegrast Impurity 92
Lifitegrast Impurity 92
CAS No.2605229-68-1
Chemical FormulaC15H18ClNO4
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 93 structure
93
利非司特杂质93Lifitegrast Impurity 93
Lifitegrast Impurity 93
CAS No.157942-12-6
Chemical FormulaC8H7IO3
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 94 structure
94
利非司特杂质94Lifitegrast Impurity 94
Lifitegrast Impurity 94
CAS No.478169-68-5
Chemical FormulaC13H16O3Si
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 95 structure
95
利非司特杂质95Lifitegrast Impurity 95
Lifitegrast Impurity 95
CAS No.1270324-69-0
Chemical FormulaC10H13NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 97 structure
97
利非司特杂质97Lifitegrast Impurity 97
Lifitegrast Impurity 97
CAS No.1195655-47-0
Chemical FormulaC10H13NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 99 structure
99
利非司特杂质99Lifitegrast Impurity 99
Lifitegrast Impurity 99
CAS No.58123-77-6
Chemical FormulaC7H5IO3
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 100 structure
100
利非司特杂质100Lifitegrast Impurity 100
Lifitegrast Impurity 100
CAS No.2091680-73-6
Chemical FormulaC12H14O3Si
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 101 Hydrochloride structure
101
利非司特杂质101 盐酸盐Lifitegrast Impurity 101 Hydrochloride
Lifitegrast Impurity 101 Hydrochloride
CAS No.2097068-75-0
Chemical FormulaC10H11NO2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 101 structure
101
利非司特杂质101Lifitegrast Impurity 101
Lifitegrast Impurity 101
CAS No.933752-32-0
Chemical FormulaC10H11NO2
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 102 structure
102
利非司特杂质102Lifitegrast Impurity 102
Lifitegrast Impurity 102
CAS No.261360-77-4
Chemical FormulaC14H18BrNO4
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 103 structure
103
利非司特杂质103Lifitegrast Impurity 103
Lifitegrast Impurity 103
CAS No.1270140-83-4
Chemical FormulaC10H13NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 109 structure
109
利非司特杂质109Lifitegrast Impurity 109
Lifitegrast Impurity 109
CAS No.2889431-14-3
Chemical FormulaC25H16Cl2N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 113 structure
113
利非司特杂质113Lifitegrast Impurity 113
Lifitegrast Impurity 113
CAS No.1213360-49-6
Chemical FormulaC11H15NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 115 structure
115
利非司特杂质115Lifitegrast Impurity 115
Lifitegrast Impurity 115
CAS No.1865726-28-8
Chemical FormulaC17H19NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 117 structure
117
利非司特杂质117Lifitegrast Impurity 117
Lifitegrast Impurity 117
CAS No.2098810-32-1
Chemical FormulaC16H16ClNO2
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 125 structure
125
利非司特杂质125Lifitegrast Impurity 125
Lifitegrast Impurity 125
CAS No.1259659-82-9
Chemical FormulaC11H15NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Lifitegrast Impurity 126 structure
126
利非司特杂质126Lifitegrast Impurity 126
Lifitegrast Impurity 126
CAS No.3078916-79-4
Chemical FormulaC11H15NO4S
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

利非司特 —— 研究文献与合成路线Lifitegrast — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 利非司特 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Lifitegrast. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. A specific chiral HPLC method for lifitegrast and determination of enantiomeric impurity in drug substance, ophthalmic product and stressed samples
    Uğur M, Bellur Atici E, Ozkan SA · Journal of pharmaceutical and biomedical analysis · 2024 · 被引 5cited 5
  2. Lifitegrast Degradation: Products and Pathways
    Štefan L, Sušanj I, Buljević J, et al. · Pharmaceutics · 2025 · 被引 1cited 1

合成路线文献Synthetic-route papers

  1. Practical Synthesis of 5,7-Dichlorotetrahydroisoquinoline-6-carboxylic Acid-Key Intermediate of Lifitegrast (Xiidra)
    Liu X, Guo H, Peng P, et al. · ACS omega · 2023
  2. Acidic hydrolytic stability of the Lifitegrast: Degradation, Method development, Validation, Synthesis, LC-MS/NMR Characterization, In silico and In vitro cytotoxicity
    Kandula JS, Gantala M, Nishad A, et al. · 2024
  3. Real-Time Monitoring of Multistep Batch and Flow Synthesis Processes of a Key Intermediate of Lifitegrast by a Combined Spectrometer System with Both Near-Infrared and Raman Spectroscopies Coupled to Partial Least-Squares
    Liu Q, Wu C, Liu H, et al. · ACS omega · 2024

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

利非司特 杂质谱研究要点Lifitegrast — impurity profiling notes

下面这些是拿到 利非司特 的 71 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 71 impurity entries for Lifitegrast, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances